Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Malignant NeoplasmCancer
Interventions
DEVICE

Virtual Reality

Virtual Reality Headset applied to the participants during chemotherapy session. Participants select their preferred virtual reality experience (i.e., nature videos, meditations, interactive applications, etc). Virtual reality (VR) by definition, is a simulated experience consisting of an experiential environment created by hardware and software technology capable of provoking sensations of real experiences. It can be further divided into 1) immersive; 2) semi-immersive; and 3) non-immersive. Immersive VR employs head-mounted display (HMD) system technology to separate users from their surroundings and engage in real-time with a three-dimensional environment generated by a computer.

OTHER

Preferred activity

Participants will engage in a preferred activity such as reading, watching television, coloring, etc. during chemotherapy.

OTHER

Questionnaires

Participants will be administered multiple pre and post intervention questionnaires including NCCN Distress thermometer, GAD-7 and CCVA.

Trial Locations (1)

33331

RECRUITING

Cleveland Clinic Florida, Maroone Cancer Center, Weston

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER